| abstract |
pharmaceutical composition, use of the pharmaceutical composition, and, methods for inducing cell death or for inhibiting the growth and/or proliferation of a tumor cell and for treating an individual. the description refers to pharmaceutical compositions comprising cd37-specific bispecific antibody molecules that bind to different epitopes of the human cd37 antigen, whose bispecific antibody molecules enhanced fc-fc interactions by binding to cd37 on the cell surface. the description also refers to the use of these pharmaceutical compositions for the treatment of cancer and other diseases. |